Alendronate Sodium is a nitrogen-containing bisphosphonate that binds bone mineral and inhibits osteoclast-mediated resorption, making it a first-line treatment for osteoporosis and other metabolic bone disorders. Simson Pharma's Alendronate Sodium reference standard and impurities support the demanding analytical requirements of this high-volume bisphosphonate category.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Alendronate Sodium Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.